Fibrosis scores showed an increasing trend in patients with high CVR; however, this difference was not significant (0.094).
← all excerpts
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.
1
—
—